Stay updated on Dolutegravir for HIV Treatment Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.

Latest updates to the Dolutegravir for HIV Treatment Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision has been updated from v3.6.4 to v3.6.5, indicating a minor update to the page template or rendering. No changes to study details, eligibility criteria, locations, or other user-facing content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision label on the study page updated from v3.6.3 to v3.6.4, indicating a new build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now displays a newer revision tag, updating from v3.6.0 to v3.6.3, indicating a maintenance version update.SummaryDifference0.0%

- Check70 days agoChange DetectedEnrollment status now shows recruitment is closed. The page also introduces new help/navigation sections (e.g., How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision marker to v3.6.0.SummaryDifference0.3%

- Check77 days agoChange DetectedThe page version updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata rather than changes to the study data.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a newer version of the page in the system. No user-visible content changes are indicated by this revision.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir for HIV Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for HIV Treatment Clinical Trial page.